TrialHIV medicine2015

Kidney disease in antiretroviral-naïve HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

A C Achhra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.